|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02186 LUYE PHARMA
Nominal 
2.710 +0.200 (+7.968%) Profitability Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| ROAA (%) | -- | 1.713% | 2.142% | 2.583% | -0.622% |
| ROAE (%) | -- | 3.653% | 4.772% | 6.584% | -1.702% |
| Return on Capital Employed (%) | -- | 2.504% | 3.069% | 4.097% | -0.881% |
Margin Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Gross Profit Margin (%) | -- | 66.721% | 68.438% | 69.220% | 65.319% |
| EBITDA Margin (%) | -- | 34.778% | 31.897% | 28.810% | 15.464% |
| Pre-tax Profit Margin (%) | -- | 13.845% | 11.397% | 11.197% | -1.434% |
| Net Profit Margin (%) | -- | 7.785% | 8.670% | 10.111% | -2.584% |
Liquidity Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Current Ratio (X) | -- | 1.236 X | 1.315 X | 1.137 X | 1.418 X |
| Quick Ratio (X) | -- | 1.151 X | 1.214 X | 1.055 X | 1.317 X |
Leverage Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Total Liabilities / Total Assets(%) | -- | 46.800% | 46.928% | 54.466% | 59.641% |
| Total Debt / Total Assets (%) | -- | 34.854% | 33.047% | 37.545% | 42.028% |
| Net Debt / Total Assets (%) | -- | 18.181% | 20.341% | 27.962% | 31.231% |
| Total Debt / Shareholders' Funds (%) | -- | 75.374% | 69.362% | 89.471% | 115.802% |
| Long Term Debt / Shareholders' Funds (%) | -- | 19.981% | 26.581% | 22.256% | 51.583% |
| Net Debt / Shareholders' Funds (%) | -- | 39.318% | 42.693% | 66.635% | 86.051% |
| Net Cash / (Debt) ($) | -- | (5.384B) | (5.185B) | (6.781B) | (7.053B) |
| Net Cash / (Debt) per share ($) | -- | (1.431) | (1.378) | (1.910) | (1.991) |
| Total Debt / Capital Employed (%) | -- | 54.774% | 48.545% | 61.674% | 62.227% |
| Interest Coverage Ratio (X) | -- | 2.494 X | 2.036 X | 2.420 X | 0.813 X |
Efficiency Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Inventory Turnover (Day) | -- | 157.398 Day | 150.676 Day | 150.596 Day | 137.485 Day |
| Receivables Turnover (Day) | -- | 154.722 Day | 123.074 Day | 108.273 Day | 116.450 Day |
| Payables Turnover (Day) | -- | 43.852 Day | 39.427 Day | 34.502 Day | 37.065 Day |
| Remarks: | Real time quote last updated: 01/04/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 618,747 |
| %Change | 31.122% |
| EPS / (LPS) | RMB 0.159 |
| NBV Per Share (¥) | RMB -- |